Biovica International AB (publ) (OM: BIOVIC B)
Health Care · Biotechnology · SE
Skr0.30
-0.33% today · -47.6% 1Y
Biovica International AB (publ) (OM: BIOVIC B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.90M.
Over the last twelve months the share price has lost 47.6%, trading between 0.27 and 0.61.
Tweenvest scores Biovica International AB (publ) across four factors: quality 37/100, value 41/100, growth 85/100. Its strongest factor is growth.
BIOVIC B price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.90M
- Revenue (TTM)
- $1.57M
- P/E
- —
- EPS
- -0.26
- Dividend yield
- —
- Beta (5Y)
- 1.22
- 52-week high
- Skr0.61
- 52-week low
- Skr0.27
- Avg volume (3M)
- —
- Shares outstanding
- 291.91M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioVie Inc.NasdaqCM: BIVI | $9.05M | $1.20 | -13.67% |
| Hemostemix Inc.TSXV: HEM | $8.97M | CA$0.06 | -20.00% |
| Poxel S.A.ENXTPA: POXEL | $8.95M | €0.15 | +10.45% |
| AdAlta LimitedASX: 1AD | $8.94M | AU$0.00 | +14.29% |
| Vistagen Therapeutics, Inc.NasdaqCM: VTGN | $8.88M | $0.20 | -15.29% |
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €— | — |
| Nanologica AB (publ)OM: NICA | $8.66M | Skr0.26 | -5.78% |
| Brainstorm Cell Therapeutics Inc.OTCPK: BCLI | $8.60M | $0.78 | -17.94% |
Figures last refreshed Oct 18, 2026.